The ruling, usually referred to as NIFLA, arose from a First Amendment challenge to California law regulating “crisis ...

The second season of 'Baylen Out Loud' premiered on Oct. 7 at 9 p.m. ET on TLC. The Tourette Syndrome advocate and TikTok ...

Roche Holding AG on Friday said a therapy it co-developed with Cambridge-based Blueprint Medicines Corp was approved by the U.S. health regulator for the treatment of patients with a type of non-small ...

A Phase 3 clinical trial testing pridopidine in people with ALS is expected to start enrolling patients in January.

Obstructive sleep apnoea (OSA) affects up to 1 billion people worldwide and is defined by repeated upper airway collapse ...

Women with androgenic alopecia and other forms of hair loss can derive meaningful benefits from a combination of follicle ...

In The Lancet Gastroenterology & Hepatology, Elyse Thakur and colleagues1 present an update of their 2020 systematic review and network meta-analysis on the efficacy of behavioural therapies for ...

FoLix, the FDA-cleared laser treatment for hair loss, provides a surgery-free option and uses existing follicles on men and ...

Rilzabrutinib (Wayrilz; Sanofi) may improve immune thrombocytopenia (ITP) outcomes, enable early intervention, and enhance patient quality of life.

Nilo Therapeutics, which launched Wednesday, is trying to develop drugs that regulate inflammation and the immune system by ...

For patients with intermediate-risk localized prostate cancer, stereotactic body radiation therapy (SBRT) yields favorable bowel health-related quality of life (HRQOL).